Seaport-based PTC Inc. (Nasdaq: PTC), one of the state's largest public companies by revenue, added 270 workers in the 12 ...

Begin your TipRanks Premium journey today. PTC Therapeutics (PTCT) Company Description: PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of ...

Fiscal '25 Constant Currency ARR Growth Guidance: 9% to 10%. PTC Inc (NASDAQ:PTC) reported a solid 25% year-over-year growth in free cash flow for fiscal 2024. The company achieved a 12% year-over ...

Begin your TipRanks Premium journey today. PTC Therapeutics (PTCT) Company Description: PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth-quarter conference call. (Operator Instructions) I would now like to turn the call over ...

Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

PTC Inc. has recently released its 10-K report, detailing its financial performance for the fiscal year ending September 30, ...

PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 Fourth Quarter Conference Call. During this presentation, all parties will be in a listen-only ...

PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

The U.S. Food and Drug Administration approved PTC Therapeutics' gene therapy to treat a potential fatal enzyme deficiency ...

Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrades for Pinterest, Editas Medicine, Gap, and Adobe, and a downgrade for PTC ...